CRP, a downstream acute-phase reactant, is similarly elevated in OA and is associated with endothelial dysfunction and atherosclerosis progression, reinforcing its relevance to cardiovascular risk [32,33]. The gene discussed is CRP; the disease is endothelial dysfunction.